News

Ophthalmology Times52m
Q&A: Christine Kay, MD, gives an investigator's perspective on the PRISM clinical trial
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Ophthalmology Times5h
Nicox releases results from Whistler phase 3b trial in IOP lowering eye drops
NCX 470, Nicox’s lead clinical product candidate, is a novel NO-donating bimatoprost eye drop with a dual mechanism of action ...
Ophthalmology Times7h
Baseline status of the central subfield ellipsoid zone predicts future visual loss
A recent analysis reveals that ellipsoidal zone-retinal pigment epithelial thickness predicts future visual loss in ...
Ophthalmology Times59m
ARVO 2025: Update on the LIGHTSITE III study in AMD
At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.
Ophthalmology Times9h
Structure-function link between ellipsoid zone integrity features and visual acuity in eyes with GA
A recent analysis reveals a strong link between photoreceptor health and visual function in geographic atrophy, emphasizing ...
Ophthalmology Times22h
ARVO 2025: Post-hoc analysis on GATHER 2 clinical trial data
Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for ...